A recent study shows that macrophages can be used to predict whether or not a melanoma patient will respond to chemotherapy. The results were published in Oncology Advances.
Of Interest
Diabetes Drug Protects Against Skin Cancer, New Research Says
TUESDAY, Jan. 14, 2025 (HealthDay News) — A popular diabetes drug can provide protection against skin cancers, a new study says.
Study identifies best imaging methods for evaluating brain tumor response in melanoma patients
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204."
Effect of Sex on Melanoma Survival Due to Clinicopathological Features
WEDNESDAY, Jan. 15, 2025 (HealthDay News) — The female survival advantage seen in melanoma is mainly a result of an indirect effect of sex mediated by clinicopathological features, according to a study published online Jan. 12 in JNCI Cancer Spectrum.